Company intelligence / Profile preview
OTCPharm
- Ownership
- Private
- Employees
- ~1000
- Development stage
- Other
Overview
OTCPharm is the leading over-the-counter (OTC) pharmaceutical company in Russia, specializing in the marketing and distribution of a wide range of consumer health products. Established in 2013 as a spin-off from Pharmstandard, the company manages a portfolio of iconic Russian brands such as Arbidol, Amixin, Pentalgin, and Complivit. Its product offerings span several therapeutic areas, including antivirals, analgesics, vitamins, and cough and cold treatments. OTCPharm operates primarily in the Russian and CIS markets, maintaining a dominant position in the retail pharmacy segment. While the company focuses on commercialization and brand management, it utilizes the manufacturing facilities of its former parent, Pharmstandard.
- Therapeutic areas
- PsychiatryNeurologyInfectious DiseasesMetabolic Disorders
- Modalities
- Small molecule
- Industry
- Biotech
Drug pipeline
8 assets7 more assets in the full pipeline.
Partnerships
Beyond the preview
Go deeper on OTCPharm.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on OTCPharm.